concept

PARKINSON'S

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARKINSON'S: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

823Connections

0Hypotheses

11Analyses

50Outgoing

50Incoming

Summary

PARKINSON'S is a concept in neurodegeneration research. Key relationships include: co discussed, causes, contributes to. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 206 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	PARKINSON'S
Summary	Page for Tremor Prediction Brain-Computer Interface
Key Genes/Proteins	SIRT1, PLP1, PARKIN
Related Diseases	PARKINSON'S DISEASE, SCHIZOPHRENIA

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

→

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

→

Pathway Diagram

graph TD
    PARKINSON_S["<b>PARKINSON'S</b>"]
    PARKINSON_S -->|"causes"| SUBSTANTIA_NIGRA["SUBSTANTIA NIGRA"]
    PARKINSON_S -->|"regulates"| PARKINSON_S_DISEASE["PARKINSON'S DISEASE"]
    PARKINSON_S -->|"causes"| PRION_DISEASE["PRION DISEASE"]
    PARKINSON_S -->|"causes"| SNCA["SNCA"]
    PARKINSON_S -->|"contributes to"| PINK1["PINK1"]
    PARKINSON_S -->|"contributes to"| STING["STING"]
    LIPID_METABOLISM["LIPID METABOLISM"] -->|"regulates"| PARKINSON_S
    OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"contributes to"| PARKINSON_S
    DOPAMINERGIC["DOPAMINERGIC"] -->|"causes"| PARKINSON_S
    NEURON["NEURON"] -->|"causes"| PARKINSON_S
    NEURONS["NEURONS"] -->|"causes"| PARKINSON_S
    PARKIN["PARKIN"] -->|"regulates"| PARKINSON_S
    PARKINSON["PARKINSON"] -->|"regulates"| PARKINSON_S
    NEURODEGENERATION["NEURODEGENERATION"] -.protects against.-> PARKINSON_S

Outgoing (228)

Target	Relation	Type	Str
NEURONS	causes_injury_to	cell_type	0.80
air pollution	implicated_in	environmental_factor	0.80
PARKINSON'S DISEASE	impairs	disease	0.65
SIRT1	protects_against	gene	0.65
PLP1	causes	gene	0.65
SCHIZOPHRENIA	causes	disease	0.65
PARKINSON'S DISEASE	accumulates_in	disease	0.65
SUBSTANTIA NIGRA	sensitizes_to	brain_region	0.65
PARKINSON'S DISEASE	expressed_in	disease	0.65
PARKINSON'S DISEASE	processes	disease	0.65
PARKINSON'S DISEASE	biomarker_for	disease	0.65
PARKINSON'S DISEASE	increases	disease	0.65
SUBSTANTIA NIGRA	reduces	brain_region	0.65
SUBSTANTIA NIGRA	causes	brain_region	0.60
PARKINSON'S DISEASE	regulates	disease	0.60
PARKINSON'S DISEASE	associated_with	disease	0.60
PARKINSON'S DISEASE	contributes_to	disease	0.60
PARKINSON'S DISEASE	protects_against	disease	0.60
PRION DISEASE	causes	disease	0.60
PARKINSON'S DISEASE	causes	disease	0.60
SNCA	causes	gene	0.60
PINK1	contributes_to	gene	0.60
SNCA	contributes_to	gene	0.60
STING	contributes_to	gene	0.60
STING	targets	gene	0.60
PARKINSON'S DISEASE	treats	disease	0.60
STING	treats	gene	0.60
PARKINSON'S DISEASE	targets	disease	0.60
T CELL	causes	cell_type	0.60
SUBSTANTIA NIGRA	expressed_in	brain_region	0.60
RIPK1	treats	gene	0.60
RIPK3	treats	gene	0.60
PARKINSON'S DISEASE	mediates	disease	0.60
PINK1	mediates	gene	0.60
SUBSTANTIA NIGRA	associated_with	brain_region	0.60
SUBSTANTIA NIGRA	degrades	brain_region	0.60
PARKINSON'S DISEASE	activates	disease	0.60
STING	activates	gene	0.60
RAF	activates	gene	0.60
RAS	activates	gene	0.60
STING	associated_with	gene	0.60
SCHIZOPHRENIA	associated_with	disease	0.60
SYNAPTIC TRANSMISSION	regulates	biological_process	0.60
RAGE	associated_with	gene	0.60
SMPD1	associated_with	gene	0.60
PARKINSON'S DISEASE	promotes	disease	0.60
STING	regulates	gene	0.60
UBIQUITIN	associated_with	gene	0.60
PINK1	interacts_with	gene	0.60
SNCA	associated_with	gene	0.60

Incoming (595)

Source	Relation	Type	Str
MICROGLIA	regulates	cell_type	0.65
PARKIN	impairs	gene	0.65
PARKINSON	impairs	disease	0.65
NEURON	activates	cell_type	0.65
NEURONS	activates	cell_type	0.65
DOPAMINERGIC	biomarker_for	cell_type	0.65
NEURON	biomarker_for	cell_type	0.65
NEURONS	biomarker_for	cell_type	0.65
NLRP3	regulates	gene	0.65
ALZHEIMER	activates	disease	0.65
ALZHEIMER'S	activates	disease	0.65
ALZHEIMER'S DISEASE	activates	disease	0.65
DEMENTIA	sensitizes_to	disease	0.65
ALS	regulates	disease	0.65
AMYOTROPHIC LATERAL SCLEROSIS	regulates	disease	0.65
HUNTINGTON	regulates	disease	0.65
HUNTINGTON'S	regulates	disease	0.65
LRRK2	regulates	gene	0.65
ALZHEIMER'S DISEASE	accumulates_in	disease	0.65
NEURODEGENERATION	accumulates_in	disease	0.65
NEURODEGENERATION	associated_with	disease	0.65
PARKIN	accumulates_in	gene	0.65
PARKINSON	accumulates_in	disease	0.65
PARKIN	sensitizes_to	gene	0.65
PARKINSON	sensitizes_to	disease	0.65
HUNTINGTON	causes	disease	0.65
HUNTINGTON'S	causes	disease	0.65
DOPAMINERGIC	accumulates_in	cell_type	0.65
NEURON	accumulates_in	cell_type	0.65
ALZHEIMER	reduces	disease	0.65
ALZHEIMER'S	reduces	disease	0.65
NEURON	sensitizes_to	cell_type	0.65
NEURONS	sensitizes_to	cell_type	0.65
ALS	causes	disease	0.65
AMYOTROPHIC LATERAL SCLEROSIS	causes	disease	0.65
MULTIPLE SCLEROSIS	causes	disease	0.65
NEURODEGENERATION	regulates	disease	0.65
ALZHEIMER	processes	disease	0.65
ALZHEIMER'S	processes	disease	0.65
PARKIN	processes	gene	0.65
PARKINSON	processes	disease	0.65
PARKIN	increases	gene	0.65
PARKINSON	increases	disease	0.65
NEURONS	accumulates_in	cell_type	0.65
DOPAMINERGIC	reduces	cell_type	0.65
NEURON	reduces	cell_type	0.65
NEURONS	reduces	cell_type	0.65
NEURODEGENERATION	processes	disease	0.65
DOPAMINERGIC	causes	cell_type	0.60
NEURON	causes	cell_type	0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (11)

Scientific analyses that reference this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

PARKINSON'S

Understanding Entity Pages

Summary

Wiki Pages (21)

Tremor Prediction Brain-Computer Interface

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Pathway Diagram

Outgoing (228)

Incoming (595)

Targeting Hypotheses (0)

Mentioning Analyses (11)

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

Are autophagy-lysosome defects primary drivers or downstream consequences in spo

Senescent cell clearance as neurodegeneration therapy

GBA-Synuclein Loop Therapeutics for PD

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

Related Papers (0)

PARKINSON'S

Understanding Entity Pages

Summary

Wiki Pages (21)

Tremor Prediction Brain-Computer Interface

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Clinical Management Guide for CBS/PSP

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

CBS/PSP Supplements Guide

Atypical Parkinsonism

Device Therapies Comparison for CBS/PSP

Parthanatos in Neurodegeneration

CBS/PSP Rehabilitation Master Guide

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome

PD Combination Therapy Matrix

Alzheimer's Disease Mechanism Index

Pathway Diagram

Outgoing (228)

Incoming (595)

Targeting Hypotheses (0)

Mentioning Analyses (11)

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

What molecular mechanisms underlie Atremorine's dramatic dopamine enhancement in

Are autophagy-lysosome defects primary drivers or downstream consequences in spo

Senescent cell clearance as neurodegeneration therapy

GBA-Synuclein Loop Therapeutics for PD

GBA-Synuclein Loop: Therapeutic Strategies for Parkinson's Disease

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

Related Papers (0)